Quest Diagnostics Inc
NYSE:DGX
Quest Diagnostics Inc
Cash from Financing Activities
Quest Diagnostics Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Quest Diagnostics Inc
NYSE:DGX
|
Cash from Financing Activities
$83m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Cash from Financing Activities
-$1.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-9%
|
|
Chemed Corp
NYSE:CHE
|
Cash from Financing Activities
-$31.8m
|
CAGR 3-Years
51%
|
CAGR 5-Years
30%
|
CAGR 10-Years
13%
|
|
CVS Health Corp
NYSE:CVS
|
Cash from Financing Activities
$2.7B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Cash from Financing Activities
-$4.3B
|
CAGR 3-Years
20%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash from Financing Activities
-$10.4m
|
CAGR 3-Years
77%
|
CAGR 5-Years
63%
|
CAGR 10-Years
26%
|
See Also
What is Quest Diagnostics Inc's Cash from Financing Activities?
Cash from Financing Activities
83m
USD
Based on the financial report for Mar 31, 2024, Quest Diagnostics Inc's Cash from Financing Activities amounts to 83m USD.